Once the connection between UCHL1 and the neurological complication of COVID-19 is firmly established, the presence of this molecule could be used for the early diagnosis of neurological disorder caused by SARS-CoV-2 attack and favor the therapeutic intervention of COVID-19 patients. Here, UCHL1 is linked to nervous system disorder.